Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
about
Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoidsThe N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membraneReduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasisDHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteinsModulation by cytokines of glucocorticoid action.Cortisol metabolism, cortisol sensitivity and the pathogenesis of leprosy reactions.Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance.Regulation of 11β-hydroxysteroid dehydrogenase type 1 and 7α-hydroxylase CYP7B1 during social stressGlucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.Activated glucocorticoid and eicosanoid pathways in endometriosis.Interleukin 7 regulates the survival and generation of memory CD4 cells.Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas.Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.Adrenal insufficiency in critical illness.Evidence for glucocorticoid-mediated hypertension after uninephrectomyEpigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expressionElevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease.Glucocorticoid metabolism in rheumatoid arthritis.In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3.Local glucocorticoid production in the mouse lung is induced by immune cell stimulation.Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice.The relation between long-term cortisol levels and the metabolic syndrome in HIV-infected patients.Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss.Impaired hypothalamo-pituitary-adrenal axis in patients with ankylosing spondylitis.Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.TNF-alpha enhances intracellular glucocorticoid availability.Glucocorticoids and 11 beta-hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney.Increased expression of 11 beta-hydroxysteroid dehydrogenase type 2 in the lungs of patients with acute respiratory distress syndrome.Prostaglandin F2alpha stimulates 11Beta-hydroxysteroid dehydrogenase 1 enzyme bioactivity and protein expression in bovine endometrial stromal cells.The effects of chorioamnionitis and betamethasone on 11beta hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor in preterm human placenta.Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways.11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation.Effects of menopause on hepatic 11β-hydroxysteroid dehydrogenase type 1 activity and adrenal sensitivity to adrenocorticotropin in healthy non-obese women.Hepatic inflammation induced by high-fructose diet is associated with altered 11βHSD1 expression in the liver of Wistar rats.Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy.Increased Cortisol
P2860
Q24800806-6BF1E790-5C7C-421B-8F29-CB79D74F73DCQ28144963-68ECE58C-221F-438F-97CB-7582006AEF9DQ28363481-CCBA723D-EFF3-4B18-85F7-3BB1F9C9766FQ28573234-CF8D0F63-956C-425A-9783-90280B999B60Q33692675-CC2793FA-B615-4859-BDE3-075D6527EBFCQ33724506-C1CCFA58-D499-483B-B6C4-C3AF5EC8DBCFQ34060256-DD0AC3CE-BB4A-499D-9C89-FAFEDA9B162FQ35107284-2B7CE2B2-6A9D-4857-A9A4-51DF1AFFB3E0Q36065521-F2B04BBA-E5D3-402B-9F4D-C1A01C2F0D03Q36074787-89EA7F3A-97F6-44F0-A393-626DE0D6E925Q36371578-50F36F47-3D27-4BC2-9684-EEE92AD1AF36Q36615861-46B99B98-83A9-4501-B1AC-752DD6D24F2AQ36694003-FE9FF328-7C0F-4B75-87C1-60F3E198DC94Q37019710-F5C43E0A-17D4-4CE7-9186-E56216815D29Q37344125-DB46FEB6-B3E7-4565-B970-CAE8E115DF9AQ37574164-E9A899EB-84BE-4653-A835-D700B677590CQ37640920-6A0F5BAF-74E6-4C2C-B7F9-35F094D6A66FQ37655884-392113B7-9080-4332-A558-9EE0497E6F15Q37924425-EE85FB14-5B3E-46AD-9FD4-869CD6335D7FQ38192016-2BC7CB29-8148-4DEC-BF93-A0DC24DD7A7DQ38291982-915C2020-E606-4C58-8D8E-127EBB1918CCQ39438218-79AAAFD8-3C3F-44FD-B24C-082F3867CFB2Q39904526-ABF809DF-832F-4804-90A9-BD605761FAC9Q39918759-57BF382D-C93A-49F5-A798-B6358606CE9AQ41084938-36E20187-1292-4023-92AA-3CCD8C85B9C2Q41859433-95DA7B25-5754-4D98-9078-4D094B150C0DQ42457220-4970D298-1194-48AF-AAD8-B21E48D7E723Q42604381-44D3ACDB-A744-4582-975D-D6007AEA916AQ43790591-CD8C7419-2D0E-4CD8-BC64-30E95DC218A0Q44024428-9AF790BF-E02D-44E4-8331-3D90AD75AFBFQ44663058-E7CC3121-39BF-4C7B-9539-9AB9341A11E2Q46183134-C9B95999-09E4-4241-A221-4A0E71F0644EQ46344369-C92887DB-CA94-4658-8FF8-27BAE6545416Q46713278-A3721C66-F5B3-4A36-98AD-FA206411431FQ47433431-3514CE3D-F02C-4720-A0A7-BDE57202930AQ49079064-75C90C45-139F-4F72-A5BA-F68A0F20D566Q52646591-64A7EFE9-8809-4822-AD19-306783C45794Q53071626-E1AB37CD-CBDA-49F4-94E6-C119CF4E8877Q53179202-DA255353-BF72-415B-96C2-3123FADB196AQ56876396-04DB837D-3018-42EC-8AE0-85E137F04F6D
P2860
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
@ast
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
@en
type
label
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
@ast
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
@en
prefLabel
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
@ast
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
@en
P2093
P2860
P356
P1476
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
@en
P2093
P2860
P304
P356
10.1084/JEM.186.2.189
P407
P577
1997-07-01T00:00:00Z